Patients with and without history of atrial fibrillation after percutaneous coronary intervention increased focus on modifiable risk factors

被引:0
|
作者
Kjoelseth, A. [1 ]
Norekvaal, T. M. [1 ]
Broers, G. [2 ]
Hendriks, J. M. [3 ]
Risom, S. S. [4 ]
Rotevatn, S. [1 ]
Wentzel-Larsen, T. [1 ]
Pettersen, T. R. [1 ]
机构
[1] Haukeland Hosp, Dept Heart Dis, Bergen, Norway
[2] Trondheim Reg & Univ Hosp, St Olavs Hosp, Clin Cardiol, Trondheim, Norway
[3] Flinders Univ S Australia, Caring Futures Inst, Coll Nursing & Hlth Sci, Adelaide, Australia
[4] Herlev Gentofte Univ Hosp, Gentofte, Denmark
关键词
D O I
10.1093/eurjcn/zvae098.095
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:I123 / I123
页数:1
相关论文
共 50 条
  • [11] Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation
    Godino, Cosmo
    Pivato, Carlo Andrea
    Rubino, Claudia
    Russi, Anita
    Cera, Michela
    Margonato, Alberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 129 : 122 - 124
  • [12] Bleeding and Thrombosis in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention
    Yang, Eunice
    Bhatt, Deepak L.
    Atwater, Brett
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 84 (10) : 886 - 888
  • [13] Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Sulzgruber, Patrick
    Hofer, Felix
    Kazem, Niema
    Hammer, Andreas
    Niessner, Alexander
    CARDIOVASCULAR DRUGS AND THERAPY, 2021, 35 (04) : 875 - 876
  • [14] Prediction of the Individual Risk of Bleeding in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Patrick Sulzgruber
    Felix Hofer
    Niema Kazem
    Andreas Hammer
    Alexander Niessner
    Cardiovascular Drugs and Therapy, 2021, 35 : 875 - 876
  • [15] Balancing the Risk of Bleeding and Stroke in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention (from the AVIATOR Registry)
    Mennuni, Marco G.
    Halperin, Jonathan L.
    Bansilal, Sameer
    Schoos, Mikkel M.
    Theodoropoulos, Kleanthis N.
    Meelu, Omar A.
    Sartori, Samantha
    Giacoppo, Daniele
    Bernelli, Chiara
    Moreno, Pedro R.
    Krishnan, Prakash
    Baber, Usman
    Lucarelli, Carla
    Dangas, George D.
    Sharma, Samin K.
    Kini, Annapoorna S.
    Tamburino, Corrado
    Chieffo, Alaide
    Colombo, Antonio
    Presbitero, Patrizia
    Mehran, Roxana
    AMERICAN JOURNAL OF CARDIOLOGY, 2015, 116 (01): : 37 - 42
  • [16] Outcomes of Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention
    Sutton, Nadia R.
    Seth, Milan
    Ruwende, Cyril
    Gurm, Hitinder S.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (09) : 895 - 904
  • [17] Antithrombotic Strategies in Patients With Atrial Fibrillation and Percutaneous Coronary Intervention
    Reinstadler, Sebastian J.
    Metzler, Bernhard
    Klug, Gert
    JAMA CARDIOLOGY, 2021, 6 (02) : 240 - 241
  • [18] D-dimer and fibrinogen indicate ischemic risk in patients with atrial fibrillation after percutaneous coronary intervention
    Gjermeni, Diona
    Anfang, Viktoria
    Szabo, Sofia
    Vetter, Hannah
    Venhoff, Ana C.
    Leggewie, Stefan
    Hesselbarth, David
    Trenk, Dietmar
    Buechsel, Martin
    Westermann, Dirk
    Olivier, Christoph B.
    THROMBOSIS JOURNAL, 2024, 22 (01):
  • [19] MANAGEMENT OF ATRIAL FIBRILLATION IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
    Mirra, M.
    Di Maio, M.
    Vitulano, G.
    Prota, C.
    Polito, M., V
    Poto, S.
    Pierro, L.
    Piscione, F.
    TRANSLATIONAL MEDICINE AT UNISA, 2014, 9 : 33 - 37
  • [20] Atrial fibrillation status in patients with ACS and percutaneous coronary intervention
    Iwanaga, Y.
    Nakai, M.
    Inoko, M.
    Miyamoto, Y.
    EUROPEAN HEART JOURNAL, 2023, 44